1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This grant may no longer be accepting applications.
The description indicates applications may be closed. Check the funder's website to confirm availability before applying.
Visit funder's website →This listing may be outdated. Verify details at the official source before applying.
Find similar grants2025 AHA Research Funding is sponsored by American Heart Association (AHA). Funds human adult stem cell research governed by ethical standards, including cloning research for developing treatments and transgenic animal models.
Get alerted about grants like this
Save a search for “American Heart Association (AHA)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The Foundation of Our Work Peer reviewers urgently needed Investigator-Initiated Research See investigator-initiated research opportunities These programs support specific areas of science deemed critical to achieving our mission and strategic objectives. The Heart Association co-funds some projects with other organizations to advance common goals.
See current topic-focused research opportunities These opportunities fund researchers from anywhere in the world working in the field of data science. Grants support investigators in all career stages, from trainees to senior scientists. See data science grant funding The Association's Quality Programs produce data from millions of patient records in vast databases for advancing scientific research.
Investigators can submit proposals to conduct research using this data.
See AHA Registry Research Opportunities Investigator-initiated Research Opportunities AHA Predoctoral Fellowship Proposal deadline: Tuesday, August 4, 2026 Enhances the training of promising students in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists, or related careers aimed at improving global health and wellbeing.
Within this award, additional collaboration money has been designated through the AHA/CHF Congenital Heart Defect Research Awards , Autism Speaks , the Barth Syndrome Foundation , the California Walnut Commission , and the Foundation for Sarcoidosis Research . AHA Postdoctoral Fellowship Proposal deadline: Wednesday, August 5, 2026 Enhances the training of postdoctoral applicants who are not yet independent.
The applicant must be embedded in an appropriate investigative group with the mentorship, support, and relevant scientific guidance of a research mentor.
Within this award, additional collaboration money has been designated through AHA/CHF Congenital Heart Defect Research Awards , the AHA/VIVA Physician Research Award , Autism Speaks , the Barth Syndrome Foundation , the California Walnut Commission , and the Foundation for Sarcoidosis Research .
Institutional Award for Undergraduate Student Training Proposal deadline: Wednesday, September 9, 2026 This award is made to qualified institutions that can offer a meaningful research experience that supports the AHA mission that encourages undergraduate college students from all disciplines to consider research careers.
AHA Institutional Research Enhancement Award (AIREA) Proposal deadline: Thursday, September 10, 2026 Stimulates research at educational institutions that provide baccalaureate or advanced degrees related to scientific research training. Eligible institutions may not have been major recipients of NIH support.
Awards provide funding for small-scale research projects related to cardiovascular diseases and brain health, enhancing the research environment at eligible institutions, and exposing students to research opportunities.
Proposal deadline: Tuesday, December 1, 2026 Supports highly promising healthcare and academic professionals in the early years of first professional appointment to assure the applicant’s future success as a research scientist in the field of cardiovascular and/or cerebrovascular disease research.
Within this award, additional collaboration money has been designated through the California Walnut Commission and the AHA/VIVA Physician Research Award .
International Visiting Professorship Award Proposal deadline has passed for funding in 2026 Novel pilot program to bring internationally based scientists to the U.S. for one week to foster scientific exchange -- to expand research experiences and collaborative opportunities for the awarded Visiting Professor and their U.S.-based host in research that aligns with the AHA mission.
Required Pre-proposal deadline has passed for funding in 2026 Supports highly innovative, high-impact research that could ultimately lead to critical discoveries or major advancements that will accelerate the field of cardiovascular and/or cerebrovascular research. The idea proposed here should not have been submitted in whole or in part in a previous proposal for AHA support.
Within this award, additional collaboration money has been designated through the American Headache Society . Ralph L. Sacco Scholarships in Brain Health Jointly funded by the American Academy of Neurology and the American Heart Association/American Stroke Association, with funds from a generous bequest by Dr. Ralph L.
Sacco, this program enables early career trainees to undertake a mentored two-year research project targeting various aspects of brain health. The 2026 awards are for MD or PhD (or equivalent doctoral degree) applicants in postdoctoral fellowship training with a focus on brain health. Projects for this cycle must focus on prevention, with a clear connection to either neurological or mental/behavioral health.
Rapid Impact Research Award Proposal deadline has passed For early- and mid-career investigators proposing innovative science studies aligned with sudden cardiac arrest/resuscitation science, Cardiovascular Kidney Metabolic (CKM) Syndrome, or stroke and/or vascular dementias.
Redefining Women’s Health: From Heart to Head to Hormones Pre-proposal deadline has passed American Heart Association Studio Red invites researchers, clinicians, entrepreneurs and innovators to submit ideas to advance groundbreaking research and novel solutions in conditions that disproportionally or distinctly impact women’s health. Four priority areas of focus are described in the program details.
Heart Transplantation Research Network Proposal deadline has passed. A collaborative network of clinician investigators whose collective research efforts will lead to enhanced management options for patients undergoing heart transplantation. Cardiac Arrest Research Team (CART) Network Required pre-proposal deadline has passed.
The American Heart Association and the Heart and Stroke Foundation of Canada and its funding partners will establish a cross-border, collaborative research network to address critical gaps in cardiac arrest and its consequences. Strategically Focused Research Network (SFRN) on Earlier Detection and Delaying Progression of Valvular Heart Disease Required pre-proposal deadline has passed.
Using Real-World Data to Address Prevalence and Treatment of Cardiovascular, Kidney and Metabolic Disease in Cancer Patients and Survivors For multidisciplinary research teams with expertise in two or more of these areas: Cardio-oncology; CKM Syndrome; health economics; epidemiology; biostatistics with experience in causal inference methods, machine learning, and CV research.
Identifying the Effects of GLP-1 Medications Among Individuals with Cardiovascular, Kidney and Metabolic Disease Research focused on evaluating the effects of GLP-1 and/or GIP agonists among individuals with cardiovascular, kidney, and metabolic disease (CKM) and/or obesity. Applicants should have experience in causal inference methods, machine learning, and cardiovascular research.
Collaborative proposals involving multidisciplinary teams are encouraged. Proposals are encouraged to leverage data sources including de-identified claims data, electronic health records and prospective cohort studies. See Quality Programs Research Using National-Level Data opportunities.
2026 American Heart Association holidays: Jan. 1, Jan. 19, March 27,May 25, July 3, Sept.
7, Nov. 26 & 27, Dec. 21-25 2026 Altum/ProposalCentral holidays: Jan.
1, Jan. 19, Feb. 16, May 25, June 19, July 3, Sept.
7, Oct. 12, Nov. 26 & 27, Dec.
28-Jan 1 " href="/cdn-cgi/l/email-protection#7b1a0b0b17023b131e1a090f5514091c">Email our applications team >
Based on current listing details, eligibility includes: Researchers adhering to AHA's ethical standards. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.